Deciphera Pharmaceuticals to Participate in Upcoming Investor Conferences

WALTHAM, Mass.--(BUSINESS WIRE)-- Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH), a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer, today announced that members of the management team will participate in fireside chats at the following investor conferences:

• TD Cowen 4th Annual Oncology Innovation Summit on Tuesday, May 30, 2023 at 8:30 AM ET (virtual)
• Jefferies Healthcare Conference on Thursday, June 8, 2023 at 2:30 PM ET in New York, NY

A live webcast of both events will be available on the “Events and Presentations” page in the “Investors” section of the Company’s website at https://investors.deciphera.com/events-presentations. A replay of the webcast will be archived on the Company’s website for 90 days following the presentation.

About Deciphera Pharmaceuticals

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. In addition to advancing multiple product candidates from our platform in clinical studies, QINLOCK® is Deciphera’s switch-control inhibitor for the treatment of fourth-line GIST. QINLOCK is approved in Australia, Canada, China, the European Union, Hong Kong, Israel, Macau, New Zealand, Switzerland, Taiwan, the United Kingdom, and the United States. For more information, visit www.deciphera.com and follow us on LinkedIn and Twitter (@Deciphera).

View source version on businesswire.com: https://www.businesswire.com/news/home/20230523005134/en/

Investor Relations:
Maghan Meyers
Argot Partners
[email protected]
212-600-1902

Media:
David Rosen
Argot Partners
[email protected]
212-600-1902

Source: Deciphera Pharmaceuticals, Inc.

You May Also Be Interested In

• Honeywell Technologies Completes Acquisition of Johnson Matthey’s Catalyst Technologies Business
• Dilosk Agrees Sale to Pepper Advantage
• PONY AI Inc. to Report Second Quarter and Interim Financial Results for 2026 on August 18, 2026